J H Hoofnagle

2.6k total citations
23 papers, 1.9k citations indexed

About

J H Hoofnagle is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, J H Hoofnagle has authored 23 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 18 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in J H Hoofnagle's work include Hepatitis B Virus Studies (16 papers), Hepatitis C virus research (12 papers) and Liver Disease Diagnosis and Treatment (10 papers). J H Hoofnagle is often cited by papers focused on Hepatitis B Virus Studies (16 papers), Hepatitis C virus research (12 papers) and Liver Disease Diagnosis and Treatment (10 papers). J H Hoofnagle collaborates with scholars based in United States and France. J H Hoofnagle's co-authors include Adrian M. Di Bisceglie, Robert L. Carithers, Nancy L. Ascher, Craig Shapiro, Francis V. Chisari, Jeanne G. Waggoner, Barbara Rehermann, Daryl Lau, Kenneth C. Micetich and Daniel F. Schafer and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

J H Hoofnagle

22 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J H Hoofnagle United States 17 1.5k 1.4k 239 234 173 23 1.9k
Linda Scully Canada 17 1.0k 0.7× 906 0.6× 308 1.3× 91 0.4× 98 0.6× 29 1.3k
Kentaro Yoshioka Japan 27 1.7k 1.2× 1.7k 1.2× 116 0.5× 255 1.1× 93 0.5× 89 2.3k
Jean-Pierre Benhamou France 13 1.5k 1.0× 1.4k 1.0× 354 1.5× 94 0.4× 45 0.3× 18 1.8k
Liang‐Yen Wang Taiwan 30 2.4k 1.6× 2.3k 1.6× 244 1.0× 133 0.6× 40 0.2× 101 3.0k
Marielle Cohard France 12 943 0.6× 1.1k 0.8× 297 1.2× 394 1.7× 29 0.2× 22 1.9k
Gian Lodovico Rapaccini Italy 24 910 0.6× 1.1k 0.7× 436 1.8× 229 1.0× 50 0.3× 51 1.9k
Ulrich Treichel Germany 25 1.2k 0.8× 814 0.6× 898 3.8× 225 1.0× 161 0.9× 56 2.1k
Syed Hissar India 22 1.1k 0.7× 1.3k 0.9× 173 0.7× 177 0.8× 63 0.4× 73 1.7k
Kazuhiko Sekiyama Japan 15 680 0.5× 527 0.4× 198 0.8× 81 0.3× 91 0.5× 27 913
Alexandra L. Gibas United States 9 1.9k 1.3× 1.9k 1.3× 87 0.4× 102 0.4× 48 0.3× 12 2.3k

Countries citing papers authored by J H Hoofnagle

Since Specialization
Citations

This map shows the geographic impact of J H Hoofnagle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J H Hoofnagle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J H Hoofnagle more than expected).

Fields of papers citing papers by J H Hoofnagle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J H Hoofnagle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J H Hoofnagle. The network helps show where J H Hoofnagle may publish in the future.

Co-authorship network of co-authors of J H Hoofnagle

This figure shows the co-authorship network connecting the top 25 collaborators of J H Hoofnagle. A scholar is included among the top collaborators of J H Hoofnagle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J H Hoofnagle. J H Hoofnagle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoofnagle, J H & Adrian M. Di Bisceglie. (1997). TREATMENT OF CHRONIC VIRAL HEPATITIS. 336(5). 347–512. 15 indexed citations
2.
Mangia, Alessandra, Young-Hwa Chung, J H Hoofnagle, et al.. (1996). Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg. Digestive Diseases and Sciences. 41(12). 2447–2452. 36 indexed citations
3.
Rehermann, Barbara, Daryl Lau, J H Hoofnagle, & Francis V. Chisari. (1996). Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.. Journal of Clinical Investigation. 97(7). 1655–1665. 248 indexed citations
4.
Hoofnagle, J H, Robert L. Carithers, Craig Shapiro, & Nancy L. Ascher. (1995). Fulminant hepatic failure: Summary of a workshop. Hepatology. 21(1). 240–252. 435 indexed citations
5.
Hosein, Barbara, Fang Chen, Michiko Shindo, et al.. (1994). Diagnosis of chronic hepatitis C: comparison of immunoassays and the polymerase chain reaction.. PubMed. 89(4). 493–6. 19 indexed citations
6.
Fried, Michael, et al.. (1993). Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis. Digestive Diseases and Sciences. 38(4). 631–636. 56 indexed citations
7.
Hoofnagle, J H, Adrian M. Di Bisceglie, Jeanne G. Waggoner, & Yoon Park. (1993). Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology. 104(4). 1116–1121. 166 indexed citations
8.
Fried, Michael, Adrian M. Di Bisceglie, Yoon Park, et al.. (1992). A Pilot Study of 2′,3′–Dideoxyinosine for the Treatment of Chronic Hepatitis B. Hepatology. 16(4). 861–864. 32 indexed citations
9.
Bisceglie, Adrian M. Di, Stanley E. Order, J Klein, et al.. (1991). The role of chronic viral hepatitis in hepatocellular carcinoma in the United States.. PubMed. 86(3). 335–8. 128 indexed citations
10.
Peters, Marion G., John M. Vierling, Eric M. Gershwin, et al.. (1991). Immunology and the liver. Hepatology. 13(5). 977–994. 120 indexed citations
11.
Hoofnagle, J H & Adrian M. Di Bisceglie. (1991). Serologic Diagnosis of Acute and Chronic Viral Hepatitis. Seminars in Liver Disease. 11(2). 73–83. 116 indexed citations
12.
Hoofnagle, J H, et al.. (1989). Therapy of Chronic Viral Hepatitis: Past, Present, and Future. Seminars in Liver Disease. 9(4). 231–234. 13 indexed citations
13.
Negro, Francesco, Ferruccio Bonino, Adrian M. Di Bisceglie, J H Hoofnagle, & J. L. Gerin. (1989). Intrahepatic markers of hepatitis delta virus infection. A study by hybridization. Journal of Hepatology. 9. S196–S196. 17 indexed citations
14.
Peters, Marion G., Dennis M. Walling, Kathleen Kelly, et al.. (1986). Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis.. The Journal of Immunology. 137(10). 3147–3152. 35 indexed citations
15.
Hoofnagle, J H, Geoffrey Dusheiko, Daniel F. Schafer, et al.. (1982). Reactivation of Chronic Hepatitis B Virus Infection by Cancer Chemotherapy. Annals of Internal Medicine. 96(4). 447–449. 325 indexed citations
16.
Tabor, Edward, J H Hoofnagle, L. A. Smallwood, et al.. (1979). Studies of Donors Who Transmit Posttransfusion Hepatitis. Transfusion. 19(6). 725–731. 61 indexed citations
17.
Hoofnagle, J H, et al.. (1978). Variation in Gamma Counter Efficiency Used in Radioimmunoassay Testing for Hepatitis B Surface Antigen and Antibody. Transfusion. 18(1). 91–93. 2 indexed citations
18.
Hoofnagle, J H, et al.. (1977). Type B hepatitis in Iran.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20(3-4). 105–10. 5 indexed citations
19.
Hoofnagle, J H, et al.. (1975). Hepatitis A Antigen in Liver, Bile and Stool. Proceedings annual meeting Electron Microscopy Society of America. 33. 340–341. 1 indexed citations
20.
Markenson, Joseph A., et al.. (1975). The interaction of rheumatoid factor with hepatitis B surface antigen-antibody complexes.. PubMed. 19(2). 209–17. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Scully Breakdown of academic impact, for papers by Kentaro Yoshioka Breakdown of academic impact, for papers by Jean-Pierre Benhamou Breakdown of academic impact, for papers by Liang‐Yen Wang Breakdown of academic impact, for papers by Marielle Cohard Breakdown of academic impact, for papers by Gian Lodovico Rapaccini Breakdown of academic impact, for papers by Ulrich Treichel Breakdown of academic impact, for papers by Syed Hissar Breakdown of academic impact, for papers by Kazuhiko Sekiyama Breakdown of academic impact, for papers by Alexandra L. Gibas
Rankless by CCL
2026